Hospira plans to complete offer
LAKE FOREST - Hospira Inc., a global specialty pharmaceutical and medication delivery company, announced its intention to complete the tender offer by Discus Acquisition Corp., a wholly owned Hospira subsidiary, for all outstanding shares of the common stock of Javelin Pharmaceuticals Inc. Javelin notified Hospira that it will deliver a closing certificate in accordance with the merger agreement among the parties, confirming the accuracy of its representations and warranties as of the end of the current offer period.
Article Comments
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked.
If a comment violates these standards or our terms of service, click the "flag" link in the lower-right corner of the comment box. To find our more, read our FAQ.